版本:
中国

BRIEF-Valeant announces sale of Inova Pharmaceuticals for $930 mln

June 8 Valeant Pharmaceuticals International Inc

* Valeant announces sale of Inova Pharmaceuticals for $930 million

* Valeant - deal for $930 million in cash.

* Valeant - ‍will use proceeds from sale to permanently repay term loan debt under its senior secured credit facility​

* Valeant - ‍valeant will use proceeds from sale to permanently repay term loan debt under its senior secured credit facility​

* Valeant says transaction is expected to close in second half of 2017

* Valeant - agreement to sell inova pharmaceuticals business to company owned by funds advised and managed by pacific equity partners and carlyle group Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐